Investigation of the drug effects on residual renal function through a hemodialysis patient with coronary heart disease
XIE Ya-jun
PEI Fei
ZHANG Qing-xia
Abstract：One 41-year-old male patient with chronic renal inadequacy treated with hemodialysis was admitted into hospital because of onset of chest discomfort for 6 days. The diagnosis was coronary atherosclerotic heart disease, unstable angina pectoris. The patient was given antiplatelet drugs, anti-myocardial ischemia drugs and intensive lipid-lowering therapy in the hospitalization period. Clinical pharmacist paid more attention to the investigation of the drug effects on residual renal function. ACEI/ARB could slower the descending speed of residual renal function for the patient with hemodialysis, and had protective effects on it. The incidence of renal damage by rosuvastatin was signiifcantly higher than that of the other statins, which was suggested to avoid using on the patient with hemodialysis. The patient recovered well after treatment and renal function did not decrease.
Keywords：HemodialysisCoronary heart diseaseResidual renal functionRosuvastatinClinical pharmacist
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 223-226 )